All the news Showing 10 of 30 articles from: GermanyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis E One-third of chronic hepatitis E cases transmitted through blood products Healio Hepatology / 16 April 2018 Pan-genotypic regimens 8-week treatment for hepatitis C with Maviret highly effective in people without cirrhosis Keith Alcorn / 13 April 2018 An eight-week course of treatment with the combination of glecaprevir and pibrentasvir (Maviret) is highly effective in curing hepatitis C infection in people without cirrhosis, results of two real-world studies presented at the ... Hepatitis E High hepatitis E incidence in Germany linked to raw pork intake Healio Hepatology / 03 April 2018 Sex between men High rate of hepatitis C reinfection in German men who have sex with men Keith Alcorn / 03 November 2017 Around one in seven gay and bisexual men cured of hepatitis C at major treatment centres in Germany has become reinfected since 2014, according to findings from the German Hepatitis ... Hepatitis A Warning of hepatitis A outbreak among men who have sex with men in Europe Keith Alcorn / 29 March 2017 An outbreak of hepatitis A in Europe has affected 287 people in at least 13 countries, with large numbers of cases in the United Kingdom, Italy, Spain, Germany and the ... Hepatitis delta Lonafarnib lowers hepatitis delta levels with acceptable side-effects Liz Highleyman / 27 January 2017 The hepatitis delta virus (HDV) assembly inhibitor lonafarnib reduces HDV viral load and can be safely boosted with ritonavir to allow for higher and more effective doses with acceptable gastrointestinal ... Treatment outcomes Real-world studies show 8-week sofosbuvir/ledipasvir course just as effective as 12-week course for genotype 1 patients without cirrhosis Keith Alcorn / 02 December 2016 An 8-week course of treatment with sofosbuvir/ledipasvir is just as effective as a 12-week course of treatment in people without cirrhosis, including those with HIV/hepatitis C virus (HCV) co-infection, and could significantly reduce ... Interferon-free regimens Six weeks of sofosbuvir/ledipasvir cures genotype 1 acute hepatitis C in people without HIV Liz Highleyman / 30 November 2016 A short course of sofosbuvir/ledipasvir (Harvoni) taken for 6 weeks cured 100% of HIV-negative people with genotype 1 acute hepatitis C virus (HCV) infection, including those with high viral loads, according to study results ... National policy Bayer warns planned German price curbs may restrict drug access Business Times / 15 November 2016 Interferon-free regimens Sofosbuvir/velpatasvir in chronic hepatitis C: hint of added benefit in two of ten subindications IQWIG / 17 October 2016 ← Prev123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive